ExploreWatchlistsPricing
  1. JP-listed companies
  3. Financials
  4. Capital expenditures

(3417)

Market cap
¥15.4B
P/E ratio
11.2x
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2026-1,321-53.52%
Mar 31, 2025-2,842+925.99%
Mar 31, 2024-277+18.38%
Mar 31, 2023-234+157.14%
Mar 31, 2022-91-28.91%
Mar 31, 2021-128-69.01%
Mar 31, 2020-413+2.74%
Mar 31, 2019-402+27.22%
Mar 31, 2018-316+97.50%
Mar 31, 2017-160-1.84%
Mar 31, 2016-163

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat